Am Heart J

1. BROWN JY, Drakeley S, Duncan M, Knapp WP, et al
   Moderate Intensity Exercise in Pregnant Patients with Cardiovascular Disease: A Pilot Study.
   Am Heart J. 2023 Apr 16:S0002-8703(23)00090-X. doi: 10.1016/j.ahj.2023.
   

   >> Share

   
   

   
   Am J Cardiol

2. ALFONSO F, Del Val D
   Management of Patients With Myocardial Infarction After Coronary Surgery: The Importance of Repeat Revascularization.
   Am J Cardiol. 2023 Apr 17:S0002-9149(23)00160.
   

   >> Share

   
   
3. BRUSH JE JR, Chaudhry SI, Dreyer RP, D'Onofrio G, et al
   Sex Differences in Symptom Complexity and Door-to-Balloon Time in Patients With ST-Elevation Myocardial Infarction.
   Am J Cardiol. 2023 Apr 14:S0002-9149(23)00148.
   

   >> Share

   
   
4. CUTLIP DE
   High-Intensity Statins Before Percutaneous Coronary Intervention in Acute Coronary Syndrome-Should It Be Added to Treatment Algorithm?
   Am J Cardiol. 2023 Apr 12:S0002-9149(23)00161.
   

   >> Share

   
   

   
   Am J Med

5. FREEMAN AM, Raman SV, Aggarwal M, Maron DJ, et al
   Corrigendum to 'Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making' The American Journal of Medicine 136:03 (2023); 260-269.e7.
   Am J Med. 2023 Apr 15:S0002-9343(23)00221-8. doi: 10.1016/j.amjmed.2023.
   

   >> Share

   
   

   
   Angiology

6. OZKAN E, Erdogan A, Karagoz A, Tanboga IH, et al
   Comparison of Systemic Immune-Inflammation Index and Naples Prognostic Score for Prediction Coronary Artery Severity Patients Undergoing Coronary Computed Tomographic Angiography.
   Angiology. 2023 Apr 15:33197231170979. doi: 10.1177/00033197231170979.
   

   >> Share

   
   
7. SAYLIK F, Cinar T, Selcuk M, Akbulut T, et al
   Evaluation of Naples Score for Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
   Angiology. 2023 Apr 14:33197231170982. doi: 10.1177/00033197231170982.
   

   >> Share

   
   

   
   Ann Intern Med

8. OSERAN AS, Wadhera RK, Orav EJ, Figueroa JF, et al
   Effect of Medicare Advantage on Hospital Readmission and Mortality Rankings.
   Ann Intern Med. 2023;176:480-488.
   

   >> Share

   
   

   
   Can J Cardiol

9. YU C, Meier S, Bestrawos D, Sun D, et al
   Role of cardiac magnetic resonance imaging and troponin-T in definitive diagnosis of Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA).
   Can J Cardiol. 2023 Apr 18:S0828-282X(23)00310.
   

   >> Share

   
   

   
   Circ Cardiovasc Imaging

10. LU ZN, Chen Q, Lam YY, Song G, et al
    Imaging for Transcatheter Mitral Valve Edge-to-Edge Repair for an Unusual Cause of Cardiogenic Shock.
    Circ Cardiovasc Imaging. 2022 Dec 2:e014588. doi: 10.1161/CIRCIMAGING.122.014588
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

11. DOAN TT, Sachdeva S, Bonilla-Ramirez C, Reaves-O'Neal DL, et al
    Ischemia in Anomalous Aortic Origin of a Right Coronary Artery: Large Pediatric Cohort Medium-Term Outcomes.
    Circ Cardiovasc Interv. 2023;16:e012631.
    

    >> Share

    
    
12. RYMER JA, Secemsky EA
    Use of Intravascular Ultrasound to Optimize Peripheral Vascular Interventions: How Do We Optimize Outcomes and Improve Uptake?
    Circ Cardiovasc Interv. 2023;16:e013016.
    

    >> Share

    
    
13. NANNA MG, Wang SY, Damluji AA
    Management of Stable Angina in the Older Adult Population.
    Circ Cardiovasc Interv. 2023;16:e012438.
    

    >> Share

    
    

    
    Circ Genom Precis Med

14. 
    Correction to: Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circ Genom Precis Med. 2023;16:e000093.
    

    >> Share

    
    
15. DIKILITAS O, Sherafati A, Saadatagah S, Satterfield BA, et al
    Familial Hypercholesterolemia in the Electronic Medical Records and Genomics Network: Prevalence, Penetrance, Cardiovascular Risk, and Outcomes After Return of Results.
    Circ Genom Precis Med. 2023;16:e003816.
    

    >> Share

    
    

    
    Circ Heart Fail

16. JENTZER JC, Miller PE, Alviar C, Yalamuri S, et al
    Exposure to Arterial Hyperoxia During Extracorporeal Membrane Oxygenator Support and Mortality in Patients With Cardiogenic Shock.
    Circ Heart Fail. 2023;16:e010328.
    

    >> Share

    
    

    
    Circ Res

17. SCHUETT K, Marx N, Lehrke M
    The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy.
    Circ Res. 2023;132:902-914.
    

    >> Share

    
    

    
    Circulation

18. EZAD SM, Ryan M, Donker DW, Pappalardo F, et al
    Unloading the Left Ventricle in Venoarterial ECMO: In Whom, When, and How?
    Circulation. 2023;147:1237-1250.
    

    >> Share

    
    
19. O'DONOGHUE ML, Giugliano RP, Sabatine MS
    Response by O'Donoghue et al to Letter Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".
    Circulation. 2023;147:1258-1259.
    

    >> Share

    
    
20. ZHOU X, Sun P, Yang Q
    Letter by Zhou et al Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".
    Circulation. 2023;147:1256-1257.
    

    >> Share

    
    

    
    Clin Cardiol

21. WANG B, Liu X, Hao W, Fan J, et al
    Comorbid obstructive sleep apnea is associated with adverse cardiovascular outcomes in female patients with acute coronary syndrome complicating metabolic syndrome.
    Clin Cardiol. 2023 Apr 14. doi: 10.1002/clc.24020.
    

    >> Share

    
    
22. CATAPANO AL, De Caterina R, Jukema JW, Klempfner R, et al
    Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative.
    Clin Cardiol. 2023;46:407-415.
    

    >> Share

    
    
23. WANG H, Li L, Ma Y
    Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study.
    Clin Cardiol. 2023 Apr 14. doi: 10.1002/clc.24002.
    

    >> Share

    
    

    
    Eur Heart J

24. GENTILE D, Iannaccone M, Chieffo A
    Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What's next?
    Eur Heart J. 2023;44:1357-1359.
    

    >> Share

    
    
25. GIACOPPO D, Alvarez-Covarrubias HA, Koch T, Cassese S, et al
    Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
    Eur Heart J. 2023;44:1343-1357.
    

    >> Share

    
    
26. NDREPEPA G, Kastrati A
    P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes.
    Eur Heart J. 2023;44:1371-1373.
    

    >> Share

    
    
27. KANG J, Rizas KD, Park KW, Chung J, et al
    Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
    Eur Heart J. 2023;44:1360-1370.
    

    >> Share

    
    
28. CREA F
    Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding.
    Eur Heart J. 2023;44:1287-1290.
    

    >> Share

    
    

    
    Heart

29. KUMAR A, Sanghera A, Sanghera B, Mohamed T, et al
    Chest pain symptoms during myocardial infarction in patients with and without diabetes: a systematic review and meta-analysis.
    Heart. 2023 Apr 20:heartjnl-2022-322289. doi: 10.1136/heartjnl-2022-322289.
    

    >> Share

    
    

    
    Hypertension

30. BOMBELLI M, Vanoli J, Facchetti R, Maloberti A, et al
    Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: a Prospective Cohort Study.
    Hypertension. 2023 Apr 19. doi: 10.1161/HYPERTENSIONAHA.122.19988.
    

    >> Share

    
    

    
    Int J Cardiol

31. FLYGARE O, Boberg J, Ruck C, Hofmann R, et al
    Association of anxiety or depression with risk of recurrent cardiovascular events and death after myocardial infarction: A nationwide registry study.
    Int J Cardiol. 2023 Apr 18:S0167-5273(23)00576.
    

    >> Share

    
    
32. ISHII M, Nakamura T, Tsujita K
    Impact of veno-arterial extracorporeal membrane oxygenation on mortality in cardiogenic shock after acute myocardial infarction: Real-world evidence.
    Int J Cardiol. 2023 Apr 13:S0167-5273(23)00521.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

33. MUKAMA T, Srour B, Johnson T, Katzke V, et al
    IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all-causes in EPIC - Heidelberg.
    J Clin Endocrinol Metab. 2023 Apr 17:dgad212. doi: 10.1210.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

34. YAMADA Y, Sadahiro T, Ieda M
    Development of direct cardiac reprogramming for clinical applications.
    J Mol Cell Cardiol. 2023;178:1-8.
    

    >> Share

    
    
35. FUJII S, Kobayashi S, Chang Y, Nawata J, et al
    RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
    J Mol Cell Cardiol. 2023 Mar 22:S0022-2828(23)00052.
    

    >> Share

    
    
36. BRLECIC PE, Bonham CA, Rosengart TK, Mathison M, et al
    Direct cardiac reprogramming: A new technology for cardiac repair.
    J Mol Cell Cardiol. 2023;178:51-58.
    

    >> Share

    
    

    
    PLoS One

37. HU Y, Zhou T, Li X, Chen X, et al
    Factors influencing return to work 3 months after percutaneous coronary intervention in young and middle-aged patients with coronary heart disease: A single-center, cross-sectional study.
    PLoS One. 2023;18:e0284100.
    

    >> Share

    
    
38. MAINO A, Sadeghian S, Mancini I, Abbasi SH, et al
    Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study.
    PLoS One. 2023;18:e0283707.
    

    >> Share

    
    
39. FUKUTA H, Goto T, Kamiya T
    Association of epicardial fat with cardiac structure and function and cardiovascular outcomes: A protocol for systematic review and meta-analysis.
    PLoS One. 2023;18:e0283482.
    

    >> Share

    
    
40. HUANG AA, Huang SY
    Use of machine learning to identify risk factors for coronary artery disease.
    PLoS One. 2023;18:e0284103.
    

    >> Share

    
    
41. RAN T, Chen J, Cheng Y, Zhang M, et al
    A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.
    PLoS One. 2023;18:e0274277.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share